Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis

AV Benjafield, NT Ayas, PR Eastwood… - The Lancet …, 2019 - thelancet.com
Background There is a scarcity of published data on the global prevalence of obstructive
sleep apnoea, a disorder associated with major neurocognitive and cardiovascular …

Obesity hypoventilation syndrome

JF Masa, JL Pépin, JC Borel, B Mokhlesi… - European …, 2019 - Eur Respiratory Soc
Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass
index≥ 30 kg· m− 2), daytime hypercapnia (arterial carbon dioxide tension≥ 45 mmHg) and …

The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the Osteoporotic Fractures in Men Study and the Sleep Heart Health Study

A Azarbarzin, SA Sands, KL Stone… - European heart …, 2019 - academic.oup.com
Aims Apnoea–hypopnoea index (AHI), the universal clinical metric of sleep apnoea severity,
poorly predicts the adverse outcomes of sleep apnoea, potentially because the AHI, a …

Association of unrecognized obstructive sleep apnea with postoperative cardiovascular events in patients undergoing major noncardiac surgery

MTV Chan, CY Wang, E Seet, S Tam, HY Lai… - Jama, 2019 - jamanetwork.com
Importance Unrecognized obstructive sleep apnea increases cardiovascular risks in the
general population, but whether obstructive sleep apnea poses a similar risk in the …

[HTML][HTML] Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled …

K Nishida, D Sawada, Y Kuwano, H Tanaka, K Rokutan - Nutrients, 2019 - mdpi.com
Short-term administration of Lactobacillus gasseri CP2305 improves stress-associated
symptoms and clinical symptoms in healthy young adults and in patients with irritable bowel …

The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial

L Taranto-Montemurro, L Messineo… - American journal of …, 2019 - atsjournals.org
Rationale: There is currently no effective pharmacological treatment for obstructive sleep
apnea (OSA). Recent investigations indicate that drugs with noradrenergic and …

European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD

B Ergan, S Oczkowski, B Rochwerg… - European respiratory …, 2019 - Eur Respiratory Soc
Background While the role of acute non-invasive ventilation (NIV) has been shown to
improve outcome in acute life-threatening hypercapnic respiratory failure in COPD, the …

Normal polysomnography parameters in healthy adults: a systematic review and meta-analysis

MI Boulos, T Jairam, T Kendzerska, J Im… - The Lancet …, 2019 - thelancet.com
Background Existing normal polysomnography values are not truly normative as they are
based on small sample sizes due to the fact that polysomnography is expensive and …

Windows into human health through wearables data analytics

DR Witt, RA Kellogg, MP Snyder, J Dunn - Current opinion in biomedical …, 2019 - Elsevier
Background Wearable sensors (wearables) have been commonly integrated into a wide
variety of commercial products and are increasingly being used to collect and process raw …

Sleep in chronic respiratory disease: COPD and hypoventilation disorders

WT McNicholas, D Hansson, S Schiza… - European respiratory …, 2019 - Eur Respiratory Soc
COPD and obstructive sleep apnoea (OSA) are highly prevalent and different clinical COPD
phenotypes that influence the likelihood of comorbid OSA. The increased lung volumes and …